Heron Therapeutics Inc
HRTX
Market Cap$321.91M
Close$
$3.67
99.4% upside
Current Fair Value
99.4% upsideUndervalued by 99.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $321.91 Million |
|---|---|
| Enterprise Value | $473.87 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.09 |
| Beta | 1.33 |
| Outstanding Shares | 153,151,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -23.8 |
|---|---|
| PEG | 29.52 |
| Price to Sales | - |
| Price to Book Ratio | -1.84 |
| Enterprise Value to Revenue | 3.22 |
| Enterprise Value to EBIT | -18.28 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | -5.28 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Heron Therapeutics Inc
CEO: Barry Quart